NCT03815968

Brief Summary

The investigators want to examine whether low salt diet can increase the amniotic fluid index in patients diagnosed with oligohydramnios and assigned for conservative management. A randomized controlled trial

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 25, 2019

Completed
7 days until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

January 25, 2019

Status Verified

January 1, 2019

Enrollment Period

10 months

First QC Date

January 19, 2019

Last Update Submit

January 23, 2019

Conditions

Keywords

oligohydroamnioslow salt diet

Outcome Measures

Primary Outcomes (1)

  • amniotic fluid volume, assessed by ultrasound

    amniotic fluid volume after two weeks

    two weeks

Secondary Outcomes (4)

  • gestational age at birth

    up to 18 weeks (until delivery)

  • induction of labor

    up to 18 weeks (until delivery)

  • labor type

    up to 18 weeks (until delivery)

  • Pregnancy and childbirth complications

    up to 18 weeks (until delivery)

Study Arms (2)

low sodium diet

EXPERIMENTAL

women diagnosed with oligohydramnios designated for conservative management applying a low-salt diet.

Other: low sodium diet

regular diet

NO INTERVENTION

women diagnosed with oligohydramnios designated for conservative management applying a regular diet.

Interventions

included in the diet mostly low sodium food. avoid tinned or smoked, food. avoid adding salt to the food.

Also known as: low salt diet
low sodium diet

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women between 24-37 weeks of gestation, single fetus, who were diagnosed with an amniotic fluid index at the 5th percentile or below, according to the current gestational age
  • No medical indication for immediate delivery

You may not qualify if:

  • Refusal to participate in the study
  • A medical recommendation for delivery within two weeks of diagnosis
  • Fetal malformation or proof of fetal infection that known to cause oligohydramnios (eg CMV).
  • Premature rupture of membrane
  • Multiple pregnancy
  • Medical contraindication to the low-salt diet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departments of Obstetrics & Gynecology, affiliated with Sackler Faculty of Medicine, Tel Aviv University

Holon, 6404519, Israel

Location

Related Publications (10)

  • Rabie N, Magann E, Steelman S, Ounpraseuth S. Oligohydramnios in complicated and uncomplicated pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017 Apr;49(4):442-449. doi: 10.1002/uog.15929.

  • Rainford M, Adair R, Scialli AR, Ghidini A, Spong CY. Amniotic fluid index in the uncomplicated term pregnancy. Prediction of outcome. J Reprod Med. 2001 Jun;46(6):589-92.

  • Koski KG, Fergusson MA. Amniotic fluid composition responds to changes in maternal dietary carbohydrate and is related to metabolic status in term fetal rats. J Nutr. 1992 Feb;122(2):385-92. doi: 10.1093/jn/122.2.385.

  • Gurekian CN, Koski KG. Amniotic fluid amino acid concentrations are modified by maternal dietary glucose, gestational age, and fetal growth in rats. J Nutr. 2005 Sep;135(9):2219-24. doi: 10.1093/jn/135.9.2219.

  • Flack NJ, Sepulveda W, Bower S, Fisk NM. Acute maternal hydration in third-trimester oligohydramnios: effects on amniotic fluid volume, uteroplacental perfusion, and fetal blood flow and urine output. Am J Obstet Gynecol. 1995 Oct;173(4):1186-91. doi: 10.1016/0002-9378(95)91350-5.

  • Doi S, Osada H, Seki K, Sekiya S. Effect of maternal hydration on oligohydramnios: a comparison of three volume expansion methods. Obstet Gynecol. 1998 Oct;92(4 Pt 1):525-9. doi: 10.1016/s0029-7844(98)00242-7.

  • Umber A, Chohan MA. Intravenous maternal hydration in third trimester oligohydramnios: effect on amniotic fluid volume. J Coll Physicians Surg Pak. 2007 Jun;17(6):336-9.

  • Rakova N, Muller DN, Staff AC, Luft FC, Dechend R. Novel ideas about salt, blood pressure, and pregnancy. J Reprod Immunol. 2014 Mar;101-102:135-139. doi: 10.1016/j.jri.2013.04.001. Epub 2013 May 30.

  • Kirksey A, Pike RL, Callahan JA. Some effects of high and low sodium intakes during pregnancy in the rat. II. Electrolyte concentrations of maternal plasma, muscle, bone and brain and of placenta, amniotic fluid, fetal plasma and total fetus in normal pregnancy. J Nutr. 1962 May;77(1):43-51. doi: 10.1093/jn/77.1.43. No abstract available.

  • Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol. 1990 May;162(5):1168-73. doi: 10.1016/0002-9378(90)90009-v.

MeSH Terms

Conditions

Oligohydramnios

Interventions

Diet, Sodium-Restricted

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Michal Levy, MD

CONTACT

Eran Weiner, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 19, 2019

First Posted

January 25, 2019

Study Start

February 1, 2019

Primary Completion

December 1, 2019

Study Completion

February 1, 2020

Last Updated

January 25, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations